Futura Medical Share Discussion Threads

[petroc] 06/7/2022 12:42

Liars gonna lie, bashers gonna bash. LiarBO's gonna post and post and post until Eroxon hits the market. What will he do then when his purpose in life is over? With so much spite and bitterness inside him I can't see him stopping the bashing, he'll just need to find a new victim. I wonder where else his naive investments have failed.

[lbo] 06/7/2022 11:17

Even pharmacists advising better diet, exercising and using nutraceuticals would be better and more appropriate treatment. Also more ethical then using a placebo gel like Med3000 especially if it’s based on deception and has no proven efficacy in any placebo controlled study



Twelve studies were chosen for analysis, all of them blinded and placebo-controlled (“nutraceutical” group versus “placebo” group). All studies must have used the IIEF-EF to measure outcomes. Studies were excluded if there were data missing, if articles could not be retrieved, or if protocol was ambiguous or unblinded. The investigators performed a meta-analysis using the data, considering outcomes to be statistically significant if the P value was less than .05.

In total, 602 patients received nutraceuticals, 559 patients received a placebo, and a variety of different compounds were included in the studies.

“The mechanism of response to placebo for erectile function is unclear; however, the increases in both nutraceutical and placebo group points towards a contributory psychological effect of the medications,” the authors concluded.

[lbo] 05/7/2022 20:24

All Futura have done is allow Reckitt to sell lubricants/arousal gels as clinically proven placebo treatments for ED. And report Med3000 to the ASA, FTC etc for being misleading if it doesn’t inform consumers that Med3000 itself has no proven effect in ED beyond a placebo. As it has not proven efficacy a placebo controlled study or even against any standard cooling lubricant/arousal gel



Placebo-nomics: how bad was what Nurofen did?

Australian courts have ordered the makers of the brand to stop repackaging identical painkillers for different pains where does marketing end and deception begin?

Lies come in a wide range of ethical shapes and sizes. There are white ones, diplomatic ones, and there are mean, self-serving ones. Apparently there are even nice, Christmassy ones.

The Australian federal court yesterday ordered the drug giant Reckitt Benckiser to stop selling identical products marketed as specific Nurofen varieties for back pain, period pain, migraine pain and tension headaches. The company admitted the drugs sold in different coloured packets all contained the same active ingredient: 342mg of ibuprofen lysine. It also sold them at almost twice the price of Nurofens standard ibuprofen products.
Whether this constitutes deception or just marketing is probably one for the lawyers to argue over. Whatever its called, such practices might appear to fall pretty unequivocally towards the self-serving whopper end of the scale

[lbo] 05/7/2022 20:14

The science of placebos is fueling quackery

The placebo effect is real. So are the ethical conundrums posed by those who would exploit the latest research advances for profit.




For many, whether or not placebo use is ethical depends partly on whether patients are being deceived and whether there is a known better treatment.
A clinician who doesnt deceive a patient, and who provides a placebo for something for which there is no known treatment, such as irritable bowel syndrome, might be ethically OK, says Jeremy Howick, of the Department of Primary Health Care Sciences, at the University of Oxford, and lead author of the Plos One study. But there is no evidence that this company is enhancing care. What they’ve been doing is completely unethical

[petroc] 05/7/2022 18:10

hxxps://www.medpagetoday.com/special-reports/exclusives/92177

'Overall, I don't think anyone knows how well MED3000 will work if it makes it to market. If it works, I don't think anyone could say how it works' A bit like paracetamol then, which also became a massive success. (BTW, LiarBO, thank you for providing this link with endless opportunities to stick it to the stock basher - you.)

[lbo] 05/7/2022 17:22

https://www.ftc.gov/system/files/documents/public_statements/996984/p114505_otc_homeopathic_drug_enforcement_policy_statement.pdfA product that contemporary technology does not understand must establish that this magic actually works. Proof is what separates an effect new to science from a swindle . . . . If a condition responds to treatment, then selling a placebo as if it had therapeutic effect directly injures the consumer. FTC v. QT, Inc., 512 F.3d 858, 862-63 (7th Cir.

[petroc] 05/7/2022 17:18

hxxps://www.medpagetoday.com/special-reports/exclusives/92177

'In some of the early Viagra trials, the placebo effect was extremely high.'

Didn't stop Viagra being a roaring success, and won't stop MED3000.

[lbo] 05/7/2022 17:16

So how effective is MED3000 really?

The first thing to note is that MED3000 has never been shown to be more effective than any control treatment - because it was the control treatment.

When Futura describe the efficacy of MED3000, they are talking about improvement seen over the course of the treatment period (which was 1 month in the first trial, 3 months in the second), known as 'change vs. baseline'.

Large improvements vs. baseline are common in the placebo groups in clinical trials of a wide range of conditions. This improvement is sometimes attributed to the 'placebo effect, implying that the placebo caused the improvement

There are many reasons why symptoms can improve over the course of a trial, of which the placebo effect is only one. To measure the actual effect of a placebo, we would need to compare the placebo to a control group who got no treatment at all. This hasn't been done for MED3000, but in trials of other placebos for various disorders, the effect of placebo over no treatment is often very small.



Odds estimates indicated the largest likelihood of placebo response occurred in men who were black, were younger than 45 years, had mild ED, and did not have diabetes. The likelihood of a placebo response decreased as ED duration increased. The frequency of common adverse events was similar between placebo responders and nonresponders



In subsequent clinical studies, a surprisingly high percentage of EDDM patients 10% to 20% claimed that the placebo "improved my erections," thus indicating a psychological basis for their ED.

[lbo] 04/7/2022 20:06

Oh dear! Same price posted repeatedly over and over!!!


mikethebike4 - 27 May 2022 - 16:17:08 - 1197

But keep it up and we will reach 100p soon


mikethebike4 - 27 May 2022 - 15:22:29 - 11975 of 12430

mikethebike4 - 27 May 2022 - 12:40:59 - 11973 of 12430

mikethebike4 - 27 May 2022 - 12:06:22 - 11971 of 12430

mikethebike4 - 27 May 2022 - 08:37:08 - 11961 of 12430

mikethebike4 - 26 May 2022 - 16:53:13 - 11955 of 12430








1. The rampers post exorbitant stock price predictions.
2. The rampers warn others they better get in now or else. Their "buy now" posts almost sound like threats.
3. They attack those who disagree with their lofty predictions. They cannot back up their arguments with a rational discussion, so they resort to petty name calling and telling others who disagree with them that they are "full of it."
5. They post their predictions over and over and over desperately hoping to move the market. They never do, because what they say is insignificant to the market. That is because no one knows who they are (see below).
6. The rampers rarely (if ever) backs up their predictions with concrete, specific numbers -

[petroc] 04/7/2022 19:51

Mikethebike is not trying to fool anyone, as far as I can see. He hasn't done any of those things that you said define a ramper, e.g. quoting massive share price rises, trying to hurry people to buy, and so on. The only person I can see trying to fool everyone is you, LiarBO, with your incessant stock bashing. All Mike does is call you out when you continue to repeat your rubbish. And who can blame him.

[lbo] 04/7/2022 15:11

I feel sorry for you. You must be getting very desperate to try get out. How sad you have now resorted to trying to fool the naive to buy in!

mikethebike4 - 03 May 2018 - 15:10:23 - 4208 of 10530

my (implied) criticism is of J7 and his antics which are blind to reality - which is that this is just the latest of JBs jam tomorrow announcements which will come to nothing like previous ones over the last 17 years.

I would like nothing more than Futura to start earning money on us shareholder's behalf - I just wish that I had the sort of job that pays me £1/4m.+ and could for 17 years get away with not even covering my own salary sales-wise with (gross) receipts


mikethebike4 - 05 Feb 2019 - 09:00:04 - 4991 of 10716
J7/bio

- I am a long way past being angry with this share - I am not getting excited like you late-comers as I have seen this situation several times with FUM over the years where great potential has been thrown away by poor decisions of the BoD


mikethebike4 - 12 Jul 2018 - 15:03:00 - 4344 of 10717

The bulk of my life savings leaving aside property are in this share - if I sell now I will lose heavily
- so, as the product is v. good, I am holding on in hope, but I concede I may lose the lot !

[mikethebike4] 04/7/2022 14:11

LBO

I feel so sorry for you - you must have a really sad life spouting endless rubbish like you do

Give it a rest it's been repeated countless times before and won't benefit for yet another repetition !

[lbo] 02/7/2022 19:25

Med3000 is only a class 2b medical device (same as flexiseq). FM57 was designed to evaluate whether the Med2005 GTN gel was superior to Med3000 as a pacebo. Med3000 was the placebo in FM57. Futura had believed Med3000 had no therapeutic effect. FM57 did not set out to measure the efficacy of Med3000. Therefore the reported effectiveness seen in FM57 was a post hoc finding.




After Phase III Failure, UK Firm Pushes Placebo to Treat Erectile Dysfunction


'https://www.asa.org.uk/rulings/pro-bono-bio-entrepreneur-ltd-a17-400871.html' target='window'>https://www.asa.org.uk/rulings/pro-bono-bio-entrepreneur-ltd-a17-400871.html

Flexiseq was a certified Class IIb medical device

FLEXISEQ (often referred to as TDT 064 in the scientific literature)

the trial was designed to evaluate whether the ketoprofen gel (IDEA-033) was superior to Flexiseq as a placebo

Flexiseq had been used as the placebo treatment in that study, and therefore the researcher had initially believed Flexiseq had no therapeutic effect. The trial did not set out to measure the efficacy of Flexiseq. We, therefore, considered that its reported effectiveness by the advertiser was a post-hoc finding